British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.
Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Int J Drug Policy. 2022 Mar;101:103574. doi: 10.1016/j.drugpo.2021.103574. Epub 2022 Jan 7.
The drug toxicity crisis continues to be a significant cause of death. Over 24,600 people died from opioid toxicity in Canada over the last 5 years. Safe supply programs are required now more than ever to address the high rate of drug toxicity overdose deaths caused by illicit fentanyl and its analogues. This study aims to identify opioid preferences and associated variables to inform further phases of safe supply program implementation.
The Harm Reduction Client Survey, an annual cross-sectional survey of people who use drugs (PWUD), was administered at harm reduction supply distribution sites in BC in October-December 2019. The survey collects information on substance use patterns, associated harms, stigma, and utilization of harm reduction services. Eligibility criteria for survey participation included aged 19 years or older; self-reported substance use of any illicit substance in the past six months, and ability to provide verbal informed consent. We conducted multivariate logistic regression to investigate associations with opioid preference. We used the dichotomized preference for either heroin or fentanyl as an outcome variable. Explanatory variables of interest included: geographic region, urbanicity, gender, age category, Indigenous identity, housing, employment, witnessing or experiencing an overdose, using drugs alone, using drugs at an observed consumption site, injection as preferred mode of use, injecting any drug, frequency of use, and drugs used in last 3 days.
Of the 621 survey participants, 405 reported a preferred opioid; of these 57.8% preferred heroin, 32.8% preferred fentanyl and 9.4% preferred prescription opioids. The proportion of participants who preferred heroin over fentanyl significantly increased with age. The adjusted odds of a participant 50 or older preferring heroin was 6.76 (95% CI: 2.78-16.41, p-value: < 0.01) times the odds of an individual 29 or under. The adjusted odds of an Indigenous participant reporting a preference for heroin compared to fentanyl was 1.75 (95% CI: 1.03-2.98, p-value: 0.04) the odds of a non-Indigenous participant reporting the same. Adjusted odds of heroin preference also differed between geographic regions within British Columbia, Canada.
Opioid preference differs by age, geographic area, and Indigenous identity. To create effective safe supply programs, we need to engage PWUD about their drugs of choice.
药物毒性危机仍是导致死亡的主要原因之一。在过去五年中,加拿大因阿片类药物毒性而死亡的人数超过 24600 人。现在比以往任何时候都更需要安全供应计划,以解决因非法芬太尼及其类似物导致的高药物毒性过量死亡。本研究旨在确定阿片类药物的偏好及其相关变量,以为进一步实施安全供应计划提供信息。
2019 年 10 月至 12 月,在不列颠哥伦比亚省的减少伤害供应点进行了“减少伤害客户调查”,这是一项针对使用毒品者(PWUD)的年度横断面调查。该调查收集了关于物质使用模式、相关危害、污名化和减少伤害服务使用情况的信息。调查参与的资格标准包括年龄在 19 岁或以上;在过去六个月内自我报告使用过任何非法药物;并能够提供口头知情同意。我们进行了多变量逻辑回归分析,以研究与阿片类药物偏好的关联。我们将偏好海洛因或芬太尼的情况作为二分类因变量。感兴趣的解释变量包括:地理位置、城市程度、性别、年龄类别、土著身份、住房、就业、目睹或经历过过量用药、单独使用药物、在观察性消费场所使用药物、首选注射方式、注射任何药物、使用频率和过去 3 天使用的药物。
在 621 名调查参与者中,有 405 人报告了首选的阿片类药物;其中 57.8%的人偏好海洛因,32.8%的人偏好芬太尼,9.4%的人偏好处方阿片类药物。偏好海洛因而非芬太尼的参与者比例随着年龄的增长而显著增加。50 岁或以上的参与者偏好海洛因的调整后优势比为 6.76(95%CI:2.78-16.41,p 值:<0.01),是 29 岁以下个体的 6.76 倍。与报告偏好芬太尼的非土著参与者相比,报告偏好海洛因的土著参与者的调整后优势比为 1.75(95%CI:1.03-2.98,p 值:0.04)。在不列颠哥伦比亚省的不同地理区域内,海洛因偏好的调整后优势比也不同。
阿片类药物的偏好因年龄、地理区域和土著身份而异。为了创建有效的安全供应计划,我们需要与使用毒品者就他们选择的药物进行沟通。